FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106487411> ?p ?o ?g. }

• W2106487411 endingPage "978" @default.
• W2106487411 startingPage "968" @default.
• W2106487411 abstract "OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy data, adverse effects, and drug interactions of sibutramine as a treatment for obesity. DATA SOURCES: English-language clinical studies, abstracts, and review articles were identified using MEDLINE, EMBASE, and a manual search from January 1980 through December 1998. References were also obtained from the reference section of published articles. STUDY SELECTION AND DATA EXTRACTION: All articles identified were evaluated for possible inclusion in this review. Evaluative and comparative data from prospective, open-label, double-blind, and controlled studies were reviewed. DATA SYNTHESIS: Sibutramine is a serotonin–norepinephrine reuptake-inhibitor effective in the treatment of obesity. It does not act as a releasing agent of these neurotransmitters. Sibutramine undergoes extensive metabolism in the liver via CYP3A4, forming two pharmacologically active metabolites. This agent has demonstrated efficacy superior to placebo in reducing weight when used as part of an integrated regimen involving behavior modification, physical activity, and a reduced-calorie intake. The most frequently reported adverse effects include dry mouth, anorexia, headache, insomnia, and constipation. Sibutramine has also been shown to substantially increase blood pressure and heart rate in some patients. CONCLUSIONS: Based on anorectic efficacy data, sibutramine, a serotonin–norepinephrine reuptake-inhibitor, is a viable therapeutic option for the treatment of obesity. Recommended candidates for this medication are patients with a body mass index (BMI) ≥30 kg/m 2 without concomitant risk factors or patients with a BMI ≥27 kg/m 2 with concomitant risk factors. Sibutramine should be used with caution in patients with a history of hypertension and should not be used in those with uncontrolled hypertension and concomitant cardiovascular disease. Further studies need to be conducted in order to identify long-term outcomes beyond one year." @default.
• W2106487411 created "2016-06-24" @default.
• W2106487411 creator A5067597514 @default.
• W2106487411 creator A5077879639 @default.
• W2106487411 date "1999-09-01" @default.
• W2106487411 modified "2023-09-24" @default.
• W2106487411 title "Sibutramine: A Serotonin–Norepinephrine Reuptake-Inhibitor for the Treatment of Obesity" @default.
• W2106487411 cites W1684647427 @default.
• W2106487411 cites W1965248019 @default.
• W2106487411 cites W1965483352 @default.
• W2106487411 cites W1979714516 @default.
• W2106487411 cites W1992656515 @default.
• W2106487411 cites W1996591405 @default.
• W2106487411 cites W1997259691 @default.
• W2106487411 cites W2009892897 @default.
• W2106487411 cites W2014556324 @default.
• W2106487411 cites W2015791180 @default.
• W2106487411 cites W2018706598 @default.
• W2106487411 cites W2020732376 @default.
• W2106487411 cites W2021830949 @default.
• W2106487411 cites W2026175678 @default.
• W2106487411 cites W2031194808 @default.
• W2106487411 cites W2050439317 @default.
• W2106487411 cites W2053050907 @default.
• W2106487411 cites W2056948537 @default.
• W2106487411 cites W2061123136 @default.
• W2106487411 cites W2071013125 @default.
• W2106487411 cites W2074213386 @default.
• W2106487411 cites W2079495255 @default.
• W2106487411 cites W2079965885 @default.
• W2106487411 cites W2080672477 @default.
• W2106487411 cites W2082356678 @default.
• W2106487411 cites W2082774798 @default.
• W2106487411 cites W2091310625 @default.
• W2106487411 cites W2095199220 @default.
• W2106487411 cites W2134362869 @default.
• W2106487411 cites W2160758064 @default.
• W2106487411 cites W2161001082 @default.
• W2106487411 cites W2164231447 @default.
• W2106487411 cites W2171728296 @default.
• W2106487411 cites W2317237918 @default.
• W2106487411 cites W2327192631 @default.
• W2106487411 cites W2336564570 @default.
• W2106487411 cites W2566492183 @default.
• W2106487411 cites W4234944065 @default.
• W2106487411 cites W4300953986 @default.
• W2106487411 cites W52869055 @default.
• W2106487411 doi "https://doi.org/10.1345/aph.18319" @default.
• W2106487411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10492502" @default.
• W2106487411 hasPublicationYear "1999" @default.
• W2106487411 type Work @default.
• W2106487411 sameAs 2106487411 @default.
• W2106487411 citedByCount "147" @default.
• W2106487411 countsByYear W21064874112012 @default.
• W2106487411 countsByYear W21064874112013 @default.
• W2106487411 countsByYear W21064874112014 @default.
• W2106487411 countsByYear W21064874112015 @default.
• W2106487411 countsByYear W21064874112016 @default.
• W2106487411 countsByYear W21064874112017 @default.
• W2106487411 countsByYear W21064874112018 @default.
• W2106487411 countsByYear W21064874112020 @default.
• W2106487411 countsByYear W21064874112021 @default.
• W2106487411 countsByYear W21064874112023 @default.
• W2106487411 crossrefType "journal-article" @default.
• W2106487411 hasAuthorship W2106487411A5067597514 @default.
• W2106487411 hasAuthorship W2106487411A5077879639 @default.
• W2106487411 hasConcept C126322002 @default.
• W2106487411 hasConcept C147583825 @default.
• W2106487411 hasConcept C170493617 @default.
• W2106487411 hasConcept C197934379 @default.
• W2106487411 hasConcept C2775864247 @default.
• W2106487411 hasConcept C2776466888 @default.
• W2106487411 hasConcept C2777369949 @default.
• W2106487411 hasConcept C2777646958 @default.
• W2106487411 hasConcept C2779177272 @default.
• W2106487411 hasConcept C2780092697 @default.
• W2106487411 hasConcept C2780780548 @default.
• W2106487411 hasConcept C2781161787 @default.
• W2106487411 hasConcept C31487548 @default.
• W2106487411 hasConcept C511355011 @default.
• W2106487411 hasConcept C544821477 @default.
• W2106487411 hasConcept C71924100 @default.
• W2106487411 hasConcept C98274493 @default.
• W2106487411 hasConceptScore W2106487411C126322002 @default.
• W2106487411 hasConceptScore W2106487411C147583825 @default.
• W2106487411 hasConceptScore W2106487411C170493617 @default.
• W2106487411 hasConceptScore W2106487411C197934379 @default.
• W2106487411 hasConceptScore W2106487411C2775864247 @default.
• W2106487411 hasConceptScore W2106487411C2776466888 @default.
• W2106487411 hasConceptScore W2106487411C2777369949 @default.
• W2106487411 hasConceptScore W2106487411C2777646958 @default.
• W2106487411 hasConceptScore W2106487411C2779177272 @default.
• W2106487411 hasConceptScore W2106487411C2780092697 @default.
• W2106487411 hasConceptScore W2106487411C2780780548 @default.
• W2106487411 hasConceptScore W2106487411C2781161787 @default.
• W2106487411 hasConceptScore W2106487411C31487548 @default.
• W2106487411 hasConceptScore W2106487411C511355011 @default.
• W2106487411 hasConceptScore W2106487411C544821477 @default.

• next